Search Results - "Diossy M"

Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.

Authors: Prosz A Sahgal P Huffman BM et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2024 May 06; Vol. 8 (1), pp. 98. Date of Electronic Publication: 2024 May 06.

Publication Type: Published Erratum

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping.

Authors: Baca SC Seo JH Davidsohn MP et al.

Source: Nature medicine [Nat Med] 2024 Mar; Vol. 30 (3), pp. 907.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Serial Functional and Genomic Analyses Illuminate Clonal Evolution in Metastatic NSCLC with 12-Year Survival.

Authors: Bakaya, Vikrant S. Schneider, Sabina A. Nguyen, Tracy et al.

Source: Current Oncology. Nov2025, Vol. 32 Issue 11, p646. 7p.

Exploring the Therapeutic Potential of Nobiletin in Nonsmall Cell Lung Cancer.

Authors: Haysom-McDowell, Adam Bartholomew, Jack Yeung, Stewart et al.

Source: BioMed Research International. 6/26/2026, Vol. 2026, p1-17. 17p.

Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India.

Authors: Mukherjee, Anindya Goyal, Pankaj Tripathi, Rupal et al.

Source: PLoS ONE. 5/15/2026, Vol. 21 Issue 5, p1-11. 11p.

Gene-Specific Outcomes After Central Nervous System Metastases in Germline BRCA1- and BRCA2-Associated Breast Cancer.

Authors: Decaminada, Alice Sunder-Plassmann, Raute Ho, Weang-Kee et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1240. 15p.

A comprehensive genomic framework for identifying genes predisposing to homologous recombination repair-deficient breast or ovarian cancer.

Authors: Camacho-Valenzuela J Matis T Roca C et al.

Source: BJC reports [BJC Rep] 2026 Apr 08; Vol. 4 (1). Date of Electronic Publication: 2026 Apr 08.

Publication Type: Journal Article

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918752188106676 Publication Model: Electronic Cited Medium: Internet ISSN: 2731-9377 (Electronic) Linking ISSN: 27319377 NLM ISO Abbreviation: BJC Rep Subsets: PubMed not MEDLINE

A Differential Depth Sequencing Method, SPRE‐Seq, for Enhancing Targeted Region Coverage in Hybridization Capture‐Based NGS.

Authors: Chen, Hui‐Juan Wang, Bing Zhang, Yi‐Ran et al.

Source: Engineering in Life Sciences. Oct2025, Vol. 25 Issue 10, p1-8. 8p.

GX15-070 enhances niraparib efficacy in ovarian cancer by promoting a shift in Mcl1-mediated DNA repair pathway from HR to NHEJ.

Authors: Sheng, Jia-Jia He, Yan Liu, Po-Wu et al.

Source: Journal of Translational Medicine. 11/11/2025, Vol. 23 Issue 1, p1-17. 17p.

Case Report of Complete Response to Olaparib in a Patient with Breast Cancer Brain Metastases.

Authors: Asazuma, Kazuki Shimomura, Akihiko Kawamura, Yukino et al.

Source: Case Reports in Oncology. Jul2024, Vol. 17 Issue 1, p773-778. 6p. 2 Illustrations.

Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate Cancer.

Authors: Thapa, Bicky Venturini, Jacopo Choudhury, Atish D. et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1702. 44p.

CXCL1 and CXCL8: Reliable and feasible biomarkers differentiating intrapulmonary metastasis from multiple primary neoplasms in non-small cell lung cancers.

Authors: Liu, Ao Sun, Tianlin Qiu, Tong et al.

Source: Cancer Biomarkers. 2025, Vol. 42 Issue 4, p1-10. 10p.

Preliminary evaluation of ShallowHRD performance compared to HRDetect in familial breast cancer tumors.

Authors: Adel Jensen, Louise Baekgaard, Caroline Hey Larsen, Mie Bohnensack et al.

Source: Scientific Reports. 8/11/2025, Vol. 15 Issue 1, p1-10. 10p.

Two Decades of Disease Evolution and Biomarker-Guided Clinical Decision Making in Metastatic Prostate Cancer.

Authors: Erazo, Tatiana Moiso, Enrico Aras, Omer et al.

Source: International Journal of Molecular Sciences. Aug2025, Vol. 26 Issue 15, p7593. 13p.

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

Authors: Prosz, Aurel Duan, Haohui Tisza, Viktoria et al.

Source: Scientific Reports. 11/23/2023, Vol. 13 Issue 1, p1-10. 10p.

Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma.

Authors: Zhou, Yong Mo, Shanlan Cui, Heyang et al.

Source: National Science Review. May2024, Vol. 11 Issue 5, p1-16. 16p.

Usefulness of BRCA and ctDNA as Prostate Cancer Biomarkers: A Meta-Analysis.

Authors: Domrazek, Kinga Pawłowski, Karol Jurka, Piotr

Source: Cancers. Jul2023, Vol. 15 Issue 13, p3452. 13p.

Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer.

Authors: Zhong, Xingyu Yang, Yuxuan He, Haodong et al.

Source: Cancer Cell International. 4/22/2025, Vol. 25 Issue 1, p1-11. 11p.

p16 Immunohistochemical Patterns in Triple-Negative Breast Cancer: Clinical and Genomic Similarities of the p16 Diffuse Pattern to pRB Deficiency.

Authors: Lee, Miseon Lee, Ahwon Choi, Byung-Ock et al.

Source: Pathobiology. 2025, Vol. 92 Issue 2, p63-76. 14p.

Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor.

Authors: Takahashi, Nobuyuki Pongor, Lorinc Agrawal, Shivam P. et al.

Source: Genome Medicine. 2/25/2025, Vol. 17 Issue 1, p1-16. 16p.